Birgitta Hope Mitchell
Physician in Salt Lake City, UT

License number
Utah 5401421-1205
Issued Date
Nov 5, 2003
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Salt Lake City, UT
Education
SUNY-STONY BROOK

Personal information

See more information about Birgitta Hope Mitchell at radaris.com
Name
Address
Phone
Birgitta Mitchell, age 48
4687 S Ledgemont Dr, Salt Lake Cty, UT 84124

Professional information

Birgitta H Mitchell Photo 1

Dr. Birgitta H Mitchell - MD (Doctor of Medicine)

Age:
48
Hospitals:
Intermountain Blood And Marrow
8th Ave & C St E SUITE 8, Salt Lake City 84143
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Intermountain Blood And Marrow
8th Ave & C St E SUITE 8, Salt Lake City 84143
University of Utah Health Care
50 North Medical Dr, Salt Lake City 84132
Education:
Medical Schools
State University of New York / Health Science Center At Stony Brook
Graduated: 2002


Birgitta Hope Mitchell Photo 2

Birgitta Hope Mitchell, Salt Lake Cty UT

Specialties:
Internist
Address:
2000 Circle Of Hope Dr, Salt Lake Cty, UT 84112
Education:
State University of New York, School of Medicine (Stony Brook) - Doctor of Medicine
Cornell University - Bachelor of Science
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine), American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)


Birgitta Mitchell Photo 3

Birgitta Mitchell, Salt Lake City UT

Work:
Birgitta Johnsson
2000 Circle Of Hope Dr, Salt Lake City, UT 84112


Birgitta Mitchell Photo 4

Methods For Generating T Lymphocytes From Hematopoietic Stem Cells

US Patent:
2013000, Jan 3, 2013
Filed:
Dec 2, 2010
Appl. No.:
13/512988
Inventors:
Gerald John Spangrude - Salt Lake City UT, US
Birgitta H. Mitchell - Salt Lake City UT, US
Jared Manning - Twin Falls ID, US
International Classification:
C12N 5/0783, C12N 5/0789, C12N 5/0775
US Classification:
435373, 435377
Abstract:
This disclosure describes methods for differentiating T cells and NK cells in vitro from hematopoietic stem cells or precursor cells. The technology is directed to methods for the production of selected populations of lymphocytes, such as T cells and NK cells. The availability of such cell populations allows for the complete reconstitution of a depleted, defective or missing lymphocyte population in a patient.